Portola Pharmaceuticals Inc. (PTLA)

20.68
NASDAQ : Health Technology
Prev Close 20.53
Day Low/High 20.56 / 21.87
52 Wk Low/High 18.18 / 56.70
Avg Volume 1.34M
Exchange NASDAQ
Shares Outstanding 66.43M
Market Cap 1.36B
EPS -4.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of November 16th Options Trading For Portola Pharmaceuticals (PTLA)

First Week Of November 16th Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the November 16th expiration.

First Week Of January 2021 Options Trading For Portola Pharmaceuticals (PTLA)

First Week Of January 2021 Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2021 expiration.

Insider Buys of 2 Down Stocks Catch My Eye

Insider Buys of 2 Down Stocks Catch My Eye

Big insider purchases at Portola Pharmaceuticals and Alta Mesa Resources could be revealing.

Interesting PTLA Put And Call Options For October 19th

Interesting PTLA Put And Call Options For October 19th

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the October 19th expiration.

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Jim Cramer weighs in on Diamondback Energy, Illinois Tool Works, Xerox, PetMed Express, STMicroelectronics, Booking and more.

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Upcoming earnings? Optimistic spin on trade? Tech rally? Jim Cramer's got the game plan for next week and he tells investors to keep their cool.

Noteworthy Monday Option Activity: PTLA, W, EHTH

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Portola Pharmaceuticals, Inc. , where a total of 6,062 contracts have traded so far, representing approximately 606,200 underlying shares.

First Week Of December 21st Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the December 21st expiration.

Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban

Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban

Company to Host Conference Call on Tuesday, February 20, 2018, at 5:00 p.m. ET

Portola Pharmaceuticals Stock Sees Short Interest Increase 14.2%

Portola Pharmaceuticals Stock Sees Short Interest Increase 14.2%

The most recent short interest data has been released for the 01/12/2018 settlement date, which shows a 553,785 share increase in total short interest for Portola Pharmaceuticals, Inc. , to 4,455,929, an increase of 14.19% since 12/29/2017.

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

The South San Francisco, Calif.-based firm said after the market close on Tuesday that the FDA has extended the review period for the company's prior approval supplement for Bevyxxa (betrixaban).

TheStreet Quant Rating: D- (Sell)